These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6825773)

  • 21. Urinary excretion of Iopamidol following intrathecal administration.
    Pitrè D; Zingales MF; Trevisan C
    Neuroradiology; 1983; 25(1):37-8. PubMed ID: 6687926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphography using water-soluble contrast medium in clinical practice.
    Benda K
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():221-39. PubMed ID: 6100766
    [No Abstract]   [Full Text] [Related]  

  • 23. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
    Bassi P; Cecchini A; Dettori P; Signorini E
    Neuroradiology; 1982; 24(2):85-90. PubMed ID: 7177375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iopamidol for myelography--practical implications.
    de Villiers PD; Snyman PJ; van Rensburg MN; Lamprecht DS; Greeff GP
    S Afr Med J; 1984 Nov; 66(18):697-8. PubMed ID: 6495113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue reaction following endobronchial application of iopamidol and ioxithalamate in rats.
    Auffermann W; Geisel T; Wohltmann D; Günther RW
    Eur J Radiol; 1988 Feb; 8(1):13-7. PubMed ID: 3356194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enzyme determination in the urine for the evaluation of kidney tolerance of the water-soluble roentgen contrast medium iopamidol].
    Hartmann HG; Jutzler GA; Bambauer R; Keller HE; Maruhn D
    Radiologe; 1984 Sep; 24(9):442-5. PubMed ID: 6494455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of iopamidol in radiologic diagnosis].
    Pokorny L; Baars HG; Monoki E; Szücs A; Kelemen J
    Rontgenblatter; 1984 Oct; 37(10):353-6. PubMed ID: 6494744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isomeric purity and supersaturation of iopamidol.
    Dawson P; Pitfield J; Skinnemoen K
    Br J Radiol; 1983 Oct; 56(670):711-3. PubMed ID: 6616135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative neurotoxicity of angiographic contrast media.
    Velaj R; Drayer B; Albright R; Fram E
    Neurology; 1985 Sep; 35(9):1290-8. PubMed ID: 3927186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Visualization, diagnostic capability and safety of iopamidol, a nonionic contrast medium in cardiovascular angiography].
    Manabe H; Kozuka T; Kimura K; Koyanagi H; Suzuki S; Handa S; Akiyama H; Hiramatsu K; Yamaguchi H; Nakanishi S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Dec; 44(12):1470-80. PubMed ID: 6531201
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of ionic and nonionic contrast media on the sickling phenomenon.
    Rao VM; Rao AK; Steiner RM; Burka ER; Grainger RG; Ballas SK
    Radiology; 1982 Jul; 144(2):291-3. PubMed ID: 7089282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [First results by means of non-ionic contrast medium (Iopamidol) in urography and angiography (author's transl)].
    Corsi M; Moretti C; Biasizzo P
    Radiol Med; 1980 Apr; 66(4):215-8. PubMed ID: 7005986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, chemistry, and physical properties of iopamidol and its analogues.
    Pitrè D; Felder E
    Invest Radiol; 1980; 15(6 Suppl):S301-9. PubMed ID: 7203940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative experimental study of central nervous system tolerability of the administration of iopamidol, metrizamide, ioxitalamate, ioxaglate and iocarmate].
    Cahn J; Borzeix MG; Cahn R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):774-8. PubMed ID: 6670839
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate.
    Gale ME; Robbins AH; Hamburger RJ; Widrich WC
    AJR Am J Roentgenol; 1984 Feb; 142(2):333-5. PubMed ID: 6607603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary clinical studies with a new non-ionic contrast medium (Iopamidol) in intravenous pyelography].
    Miyakawa M; Yoshida O
    Hinyokika Kiyo; 1984 Mar; 30(3):431-5. PubMed ID: 6380240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ionic and nonionic contrast media on the metabolism of prostaglandin E2 in rat lungs.
    Paajanen H
    Invest Radiol; 1984; 19(3):216-20. PubMed ID: 6590533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality control in urography using non-ionic contrast media (iopamidol) and induced hydration].
    Stacul F; Bazzocchi M; Zanella F; Abbona M
    Radiol Med; 1986 Mar; 72(3):138-41. PubMed ID: 3704214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of urographic contrast media.
    Kelly M; Golman K
    Invest Radiol; 1981; 16(2):159-64. PubMed ID: 7216706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.